Furthermore, we uncovered up expression of CD44 after glioma recurrence in GBM, wild-type IDH, IDH mutation, and 1p19q non-codeletion state in CGGA glioma dataset (Figures 1H–J). Here, CD44 is linked to central nervous system cancer.